title: [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
abstract: A 41-year-old man with untreated acute promyelocytic leukemia (APL) was treated with all-trans retinoic acid (ATRA) 80mg/body/day per os. Complete remission was reached in 16 day without bone marrow hypoplasia and aggravated disseminated intravascular coagulation. The chromosomal abnormality, t (15;17), which presented before therapy has not been found since the 29th day of therapy. During the course of induction therapy with ATRA, there was no complication worth of mentioning. Induction therapy with ATRA is thought to be more effective and safer than conventional chemotherapy to attain complete remission in APL. The complete remission has been maintained for 11 months with conventional postremission chemotherapy.
authors: Second Department of Internal Medicine, Mie University School of Medicine.
authors: T
authors: T
authors: Tsukada
authors: N
authors: N
authors: Mahmud
authors: M
authors: M
authors: Taniguchi
authors: T
authors: T
authors: Takahashi
authors: H
authors: H
authors: Kihira
authors: K
authors: K
authors: Kita
authors: T
authors: T
authors: Kobayashi
authors: K
authors: K
authors: Deguchi
authors: S
authors: S
authors: Shirakawa
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014212:Tretinoin